论文部分内容阅读
近年来肝病的血清酶学检测方法在不断改进。本文对61例肝硬化、肝癌患者进行了血清N-乙酰-B-D氨基葡萄糖苷酶(NAG)检测,发现检测组血清NAG活性与正常人比较存在非常显著差异(P<0.01),尤其在肝硬化患者中NAG活性与肝硬化程度有密切
In recent years, serum enzymatic detection of liver disease is continuously improved. In this paper, serum N-acetyl-BD glucosaminidase (NAG) was detected in 61 patients with cirrhosis and liver cancer. There was a significant difference (P <0.01) in serum NAG activity between the two groups (P <0.01) NAG activity in patients with cirrhosis are closely related